Intelligence Over Instinct
How Adragos uses QYOBO to replace industry belief with database-driven intelligence and outpace the competition.
In a slow-moving industry, speed is everything. Adragos relies on QYOBO for end-to-end market visibility, early supply risk warnings, and data-backed decision making – from daily operations to high-stakes M&A.
Adragos is a Munich-based CDMO with facilities across Europe and Japan. Adragos operates in a market where decisions carry significant weight – particularly in M&A and supply chain risk – and where being faster than the competition can make the difference.
In an industry prone to rumors, informal networks, and fragmented data, making high-quality decisions quickly required either deep manual research or relying on unverified market beliefs. For M&A assessments and supply risk evaluation especially, the cost of getting it wrong was too high. Adragos needed to replace instinct with structured, reliable data.
SUCCESS STORY
“I work in an industry that is rather slow, so the faster I am, the better is my chance to beat competition, and QYOBO is a catalyst to that.”
Dr. Andreas Raabe
Founder & CEO
With QYOBO, the Adragos team now has an end-to-end view of the market at their fingertips, able to assess the entire landscape at a glance and drill down into specifics when needed. Key outcomes:
Capabilities
TOP FEATURES THIS CLIENT USES
Find out which features Adragos uses to transform their pharmaceutical supply chains with speed, resilience, and sustainability.
TRANSFORM UNCERTAINITY INTO OPPORTUNITY
QYOBO eliminates the chaos of disconnected tools and siloed systems with one unified platform built for pharma. No more tool-hopping. No more delays. Just clear accountability and confident action, powered by a single source of truth across your entire organization.